Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.


Individualizing Frontline Therapy for Patients With Chronic Lymphocytic Leukemia: Putting Evidence Into Practice
  • CME
  • CE

Nichole Fisher Headshot
Nichole Fisher, RN, BSN
Anthony Perissinotti, PharmD, BCOP
Jennifer Woyach, MD
Released: April 19, 2022
Back Next


In this focused activity, Jennifer Woyach, MD; Nichole Fisher, RN, BSN; and Anthony Perissinotti, PharmD, BCOP, review multidisciplinary best practices in the frontline treatment of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), including important considerations for treatment selection.

Clinical Care Options plans to measure the educational impact of this activity, and some questions will be asked twice: once prior to the discussion that informs the best choice and then again after that specific discussion. Your responses will be aggregated for analysis, but your specific responses will not be shared.

Before continuing with this educational activity, please take a moment to answer the following question.

Back Next
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
CLL Society Logo
Supported by educational grants from
AbbVie Inc.
Eli Lilly and Company
Pharmacyclics LLC, an AbbVie Company
Janssen Biotech, Inc.
TG Therapeutics, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings